Skip to content
Saturday, November 7, 2026
Explore fascinating articles about sloth behavior, habitat,…

Zimbabwe Rejects ‘One-Sided’ American Health Aid Agreement Because of Information Apprehensions

Health funding illustration
The proposed American funding would have supported initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

The nation of Zimbabwe has turned down a significant US health deal worth $367m (272 million pounds) over five years over the United States' request for sensitive data.

This move was revealed after a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the agreement was "skewed".

An official spokesman has since clarified that the United States was demanding access to biological samples for scientific study and commercial purposes while was not willing to share the resulting advantages from any future vaccines.

"We are forced to start the difficult and regrettable process of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the United States had donated over $1.9bn in health funding to Zimbabwe over the last two decades.

A medical body in Zimbabwe has urged further dialogue to find a deal acceptable to all parties so the nation's critical HIV programme can be sustained.

Wider Background

Zimbabwe's decision comes after a similar situation in Kenya, where a high court blocked a similar health funding agreement following legal challenges were raised about the safety of Kenyans' medical information.

After resuming office recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).

USAID had overseen aid for the American government, but Trump claimed its spending was "wasteful" and his government was seeking direct bilateral agreements to enhance openness and responsibility.

As per reports, Sixteen nations in Africa have to date signed these new health pacts, representing over $18.3bn of fresh investment.

Details of the Rejected Agreement

The funds for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this collaboration would have delivered significant advantages for Zimbabwean communities, especially the 1.2 million presently receiving HIV treatment via American-funded programmes," Tremont added.

However, government spokesperson Nick Mangwana said the proposed deal was "unequal".

"Zimbabwe was being asked to provide its biological resources and data indefinitely, without any equivalent promise of access to any scientific breakthroughs – such as new medicines or tests – that could result from that shared data," his statement read.

"In essence, our nation would supply the basic resources for scientific discovery with no certainty that the end products would be accessible to our citizens if a new pandemic arise."

Sovereignty and International Frameworks

He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting structures already set up through the international health agency.

The spokesperson cited its Pandemic Benefit-Sharing scheme designed to deal with future global health emergencies.

"This system is intended to ensure that when a nation contributes its data, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to develop them."

The government's concerns over the US deal "should not be misconstrued as opposition to America," he added.

"We are open to ongoing discussions with our American counterparts on how future co-operation could be designed in a manner that respects the sovereignty and interests of both nations."

Medical Community Reaction

A leading public health body said it acknowledged the official position, but suggested that negotiations should continue since much of the country's Aids initiatives relied on foreign aid.

"In cases where specific concerns exist, such as those relating to information security or implementation frameworks, these can frequently be addressed through detailed discussion and negotiated safeguards," it said.

This impasse highlights the complex debate between receiving crucial foreign assistance and safeguarding a country's data in an increasingly interconnected world.

By

Christopher Thompson

Wildlife biologist specializing in sloth research with over a decade of field experience in Central and South American rainforests.

Slothub

Type to search articles.